Fusion's Insights - 2022/02/25
Fundraising during war, MindMaze $105m funding, Web3 into real estate and OnlineDoctor powered by AI
Fundraising during war, MindMaze $105m funding, Web3 into real estate and OnlineDoctor powered by AI
Greetings and welcome back to another issue of Fusion's Insights!
Within our role to help our clients build the future of their business, through impactful and sustainable technology-driven solutions, our team is constantly exposed to insightful content.
Fusion’s Insights is meant to provide our Ecosystem with a curated content selection, linked to innovation initiatives, on a bi-monthly basis.
Ukraine’s startup ecosystem had a pretty good 2021. Homegrown scaleup success story Grammarly hit a $13bn valuation; tech giants like Amazon, Glovo, Revolut and Solarisbank opened up offices in the country; and its IT industry grew by 36%.
2022 is looking more uncertain. This morning, Vladimir Putin has declared war on Ukraine and explosions have been heard near major cities, including Kyiv.
What does this crisis mean for founders, investors and startup employees trying to get on with their day jobs?
MindMaze, a global pioneer in the multibillion-dollar digital neurotherapeutics market, today announced it has secured a $105 million financing round to accelerate its global commercial growth plans, supercharge ongoing R&D and consolidate the clinical development pipeline of its industry-defining digital therapeutic solutions for a wide spectrum of neurological diseases.
The goal of Web3 is to recreate a new, more decentralized form of the Internet, particularly through the use of blockchain. According to the Web3 Foundation, the movement created by Gavin Wood, it aims at a fairer Internet, which will give back to users the control over their data, their identity and their destiny.
A very nice project. Where are we today? You've certainly read or heard words like blockchain, NFT, metavers... Let's go over it once again.
OnlineDoctor acquires German AI spin-off A.S.S.I.S.T. With the help of the new team, the company from eastern Switzerland aims to bring the first AI medical product in teledermatology to market.